Cargando…
Neurodevelopmental Outcomes after Hypothermia Therapy in the Era of Bayley-III
BACKGROUND: Bayley-III scales are currently used to evaluate outcomes of term infants following hypothermia therapy, while all prior reported outcomes in this population have used Bayley-II. OBJECTIVE: To determine the incidence of abnormal neurodevelopmental outcomes using Bayley III and the predic...
Autores principales: | Chalak, Lina F., DuPont, Tara L., Sánchez, Pablo J., Lucke, Ashley, Heyne, Roy J., Morriss, Michael C., Rollins, Nancy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117736/ https://www.ncbi.nlm.nih.gov/pubmed/24743133 http://dx.doi.org/10.1038/jp.2014.67 |
Ejemplares similares
-
Comparison of Bayley-2 and Bayley-3 scores at 18 months in term infants following neonatal encephalopathy and therapeutic hypothermia
por: Jary, Sally, et al.
Publicado: (2013) -
The Validity of the Bayley-III and DDST-II in Preterm Infants With Neurodevelopmental Impairment: A Pilot Study
por: Jeong, Seong Uk, et al.
Publicado: (2017) -
Do currently recommended Bayley III cutoffs overestimate motor impairment in infants born <27 weeks gestation?
por: Duncan, Andrea F., et al.
Publicado: (2015) -
Diffusion-MRI-based regional cortical microstructure at birth for predicting neurodevelopmental outcomes of 2-year-olds
por: Ouyang, Minhui, et al.
Publicado: (2020) -
Prospective Research in Infants with Mild Encephalopathy (PRIME) Identified in the First Six Hours of Life: Neurodevelopmental Outcomes at 18-22 Months
por: Chalak, Lina F, et al.
Publicado: (2018)